APA (7th ed.) Citation

Moreno, C., Aiello, A., Virgilio, R. D., Mazzotta, V., & Antinori, A. (2025). Cost-effectiveness analysis of nirmatrelvir/ritonavir in adult patients at high risk of progressing to severe COVID-19. AboutScience Srl.

Chicago Style (17th ed.) Citation

Moreno, Carolina, Andrea Aiello, Roberto Di Virgilio, Valentina Mazzotta, and Andrea Antinori. Cost-effectiveness Analysis of Nirmatrelvir/ritonavir in Adult Patients at High Risk of Progressing to Severe COVID-19. AboutScience Srl, 2025.

MLA (9th ed.) Citation

Moreno, Carolina, et al. Cost-effectiveness Analysis of Nirmatrelvir/ritonavir in Adult Patients at High Risk of Progressing to Severe COVID-19. AboutScience Srl, 2025.